| Hans-Günter Meyer-Thompson | Opioide
Reformulated OxyContin's benefit against abuse remains unclear a decade later
Reformulated OxyContin's benefit against abuse remains unclear a decade later
A decade after Purdue Pharma LP changed OxyContin in an attempt to make it more difficult to abuse, U.S. health officials found there isn't enough evidence to show an overall benefit. (MedicalXpress, USA, 09.09.2020)
https://medicalxpress.com/news/2020-09-reformulated-oxycontin-benefit-abuse-unclear.html